Investor and Analyst Reception on October 8, 2012Optimer will host an investor and analyst reception on October 8, 2012 at 9:00 a.m. Eastern time in New York City to expand on the strategy described above, provide a long-term outlook for DIFICID market penetration, and review third quarter 2012 top-line revenues. A live audio webcast of the event will be accessible on the Investors page of the Company's website at www.optimerpharma.com and may also be accessed via listen-only dial in at (877) 442-2965 for U.S. callers and +1- (760) 298-5087 for international dialers. The access code for the call is 37429762. Presentation replays will be available at the same location for 90 days following the presentation.
Optimer Introduces Strategic Initiative To Further Facilitate Patient Access To DIFICID®
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
More than 30 investing pros with skin in the game give you actionable insight and investment ideas.